The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used As Hormones Excluding Medicaments: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments. With the globalization of this market, managers ca...

9/4/2020 | Chemicals (Organic and Inorganic) & Allied Products;Vitamin;Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

The World Market for Pituitary (anterior) or Similar Hormones and Derivatives: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for pituitary (anterior) or similar hormones and derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can m...

9/4/2020 | Chemicals (Organic and Inorganic) & Allied Products;Vitamin;Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

The World Market for Insulin and Its Salts: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for insulin and its salts. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-da...

9/4/2020 | Chemicals (Organic and Inorganic) & Allied Products;Vitamin;Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

The World Market for Theophylline and Aminophylline (theophylline-ethylenediamine), Their Derivatives, and Salts Thereof: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for theophylline and aminophylline (theophylline-ethylenediamine), their derivatives, and salts thereof. With the globalization of this market, managers can no longe...

9/4/2020 | Chemicals (Organic and Inorganic) & Allied Products;Vitamin;Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

The World Market for Rye Ergot Alkaloids, Their Derivatives, and Salts Thereof: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for rye ergot alkaloids, their derivatives, and salts thereof. With the globalization of this market, managers can no longer be contented with a local view. Nor can ...

9/4/2020 | Chemicals (Organic and Inorganic) & Allied Products;Vitamin;Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

The World Market for Ephedrines and Their Salts: A 2021 Global Trade Perspective

This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for ephedrines and their salts. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-...

9/4/2020 | Chemicals (Organic and Inorganic) & Allied Products;Vitamin;Healthcare, Drugs, Pharmaceuticals, Hospitals, and Laboratories

(COVID-19 Version) Global Intravenous Ibuprofen Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Intravenous Ibuprofen market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Intravenous Ibuprofen industry and main market trends with impact of coronavir...

10/29/2020 | Drugs

(COVID-19 Version) Global Musculoskeletal Disorders Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Musculoskeletal Disorders Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Musculoskeletal Disorders Drugs industry and main market trends wit...

10/24/2020 | Drugs

(COVID-19 Version) Global Multiple Sclerosis (MS) Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Multiple Sclerosis (MS) Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Multiple Sclerosis (MS) Drugs industry and main market trends with im...

10/24/2020 | Drugs

2015-2025 Global Weight Loss Drugs Market Research by Type, End-Use and Region

Summary The global Weight Loss Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Productio...

8/9/2020 | Drugs

First
Previous
3
4
5
6
7
8
9
10
11
12
Next

9/4/2020

9/4/2020

9/4/2020

9/4/2020

9/4/2020

9/4/2020

Summary The report forecast global Intravenous Ibuprofen market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Intravenous Ibuprofen industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Intravenous Ibuprofen by geography. The report splits the market size, by volume and value, on the basis of application type and geography. First, this report covers the present status and the future prospects of the global Intravenous Ibuprofen market for 2015-2024. And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]. At the same time, we classify Intravenous Ibuprofen according to the type, application by geography. More importantly, the report includes major countries market based on the type and application. Finally, the report provides detailed profile and data information analysis of leading Intravenous Ibuprofen company. Key Content of Chapters as follows (Including and can be customized) : Part 1: Market Overview, Development, and Segment by Type, Application & Region Part 2: Company information, Sales, Cost, Margin etc. Part 3: Global Market by company, Type, Application & Geography Part 4: Asia-Pacific Market by Type, Application & Geography Part 5: Europe Market by Type, Application & Geography Part 6: North America Market by Type, Application & Geography Part 7: South America Market by Type, Application & Geography Part 8: Middle East & Africa Market by Type, Application & Geography Part 9: Market Features Part 10: Investment Opportunity Part 11: Conclusion Market Segment as follows: By Region Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia] Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland] North America[United States, Canada, Mexico] Middle East & Africa[GCC, North Africa, South Africa] South America[Brazil, Argentina, Columbia, Chile, Peru] Key Companies Cumberland Pharmaceuticals Inc Alveda Pharmaceuticals Teligent CSL Limited Sandor Medicaids Soho Industri Pharmasi Germin MED Grifols Harbin Gloria Pharmaceuticals Al Nabeel International Ltd Laboratorios Valmorca Market by Type Pain Inflammatory Fever Market by Application Pediatrics Adults Other ...

10/29/2020

Summary The report forecast global Musculoskeletal Disorders Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Musculoskeletal Disorders Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Musculoskeletal Disorders Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography. First, this report covers the present status and the future prospects of the global Musculoskeletal Disorders Drugs market for 2015-2024. And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]. At the same time, we classify Musculoskeletal Disorders Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application. Finally, the report provides detailed profile and data information analysis of leading Musculoskeletal Disorders Drugs company. Key Content of Chapters as follows (Including and can be customized) : Part 1: Market Overview, Development, and Segment by Type, Application & Region Part 2: Company information, Sales, Cost, Margin etc. Part 3: Global Market by company, Type, Application & Geography Part 4: Asia-Pacific Market by Type, Application & Geography Part 5: Europe Market by Type, Application & Geography Part 6: North America Market by Type, Application & Geography Part 7: South America Market by Type, Application & Geography Part 8: Middle East & Africa Market by Type, Application & Geography Part 9: Market Features Part 10: Investment Opportunity Part 11: Conclusion Market Segment as follows: By Region Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia] Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland] North America[United States, Canada, Mexico] Middle East & Africa[GCC, North Africa, South Africa] South America[Brazil, Argentina, Columbia, Chile, Peru] Key Companies AbbVie Amgen Johnson & Johnson F. Hoffmann-La Roche Ltd Pfizer Inc Eli Lilly Market by Type Rheumatoid Arthritis Muscle Relaxants Others Market by Application Rheumatoid Arthritis Osteoarthritis Osteoporosis Psoriatic Arthritis Ankylosing Spondylitis Others ...

10/24/2020

Summary The report forecast global Multiple Sclerosis (MS) Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Multiple Sclerosis (MS) Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Multiple Sclerosis (MS) Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography. First, this report covers the present status and the future prospects of the global Multiple Sclerosis (MS) Drugs market for 2015-2024. And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]. At the same time, we classify Multiple Sclerosis (MS) Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application. Finally, the report provides detailed profile and data information analysis of leading Multiple Sclerosis (MS) Drugs company. Key Content of Chapters as follows (Including and can be customized) : Part 1: Market Overview, Development, and Segment by Type, Application & Region Part 2: Company information, Sales, Cost, Margin etc. Part 3: Global Market by company, Type, Application & Geography Part 4: Asia-Pacific Market by Type, Application & Geography Part 5: Europe Market by Type, Application & Geography Part 6: North America Market by Type, Application & Geography Part 7: South America Market by Type, Application & Geography Part 8: Middle East & Africa Market by Type, Application & Geography Part 9: Market Features Part 10: Investment Opportunity Part 11: Conclusion Market Segment as follows: By Region Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia] Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland] North America[United States, Canada, Mexico] Middle East & Africa[GCC, North Africa, South Africa] South America[Brazil, Argentina, Columbia, Chile, Peru] Key Companies Bayer AG Bayhill Therapeutics Biogen Idec Cinnagen Daiichi Sankyo Eli Lilly Fast Forward Llc Antisense Therapeutics Apitope Five Prime Therapeutics Genmab Artielle Immunotherapeutics Genzyme Glaxosmithkline Gw Pharmaceuticals Innate Immunotherapeutics Market by Type Copaxone (Glatiramer Acetate, Copolymer 1) Novantrone (Mitoxantrone) Gilenya (Fingolimod, Fty720) Aubagio (Teriflunomide) Tecfidera (Dimethyl Fumarate) Firategrast (Sb683699, T-0047) Siponimod (Baf312) Others Market by Application RRMS SPMS PPMS PRMS ...

10/24/2020

Summary The global Weight Loss Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consumption Market by Type and End-Use Chapter 5: Asia Production & Consumption Market by Type and End-Use Chapter 6: Oceania Production & Consumption Market by Type and End-Use Chapter 7: Africa Production & Consumption Market by Type and End-Use Chapter 8: Global Market Forecast by Type, End-Use and Region Chapter 9: Company information, Sales, Cost, Margin, news etc. Chapter 10: Market Competition by Companies and Market Concentration Ratio Chapter 11: Market Impact by Coronavirus. Chapter 12: Industry Summary . Market Segment as follows: Key Companies Roche GSK group Teva Sandoz(Novartis) STADA-VN J.V.Co., Ltd Hexal AG National Company For Pharmaceutical Industry Lunan Pharmaceutical Group Corporation Zein Pharmaceutical Hisun Taj Pharmaceuticals Ltd Kabir Life Sciences & Research Dm Pharma China Zhongshan Pharm Key Types Liauid Tablets Key End-Use Weight-reducing Aid Other This report can be dispatched within 24-48 Hours. ...

8/9/2020

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT